Moral emotions, a diagnotic tool for frontotemporal dementia?

by IOS PressCredit: CC0 Public DomainA study conducted by Marc Teichmann and Carole Azuar at the Brain and Spine Institute in Paris (France) and at the Pitié-Salpêtrière Hospital shows a particul

Updated on: May 20,2024

Moral emotions, a diagnotic tool for frontotemporal dementia?

by IOS PressCredit: CC0 Public DomainA study conducted by Marc Teichmann and Carole Azuar at the Brain and Spine Institute in Paris (France) and at the Pitié-Salpêtrière Hospital shows a particul

Updated on:May 20,2024

From blurry to bright: AI tech helps researchers peer into the brains of mice

by Johns Hopkins University School of MedicineCredit: CC0 Public DomainJohns Hopkins biomedical engineers have developed an artificial intelligence (AI) training strategy to capture images of mou

Updated on: February 18,2024

From blurry to bright: AI tech helps researchers peer into the brains of mice

by Johns Hopkins University School of MedicineCredit: CC0 Public DomainJohns Hopkins biomedical engineers have developed an artificial intelligence (AI) training strategy to capture images of mou

Updated on:February 18,2024

Chemist discovers promising compound for a future drug against Alzheimer's disease

by RUDN UniversityCredit: RUDN UniversityBiochemists from RUDN University (Russia) and the University of Bari (Italy) report a group of compounds that can become a molecular scaffold for new drug

Updated on: June 07,2024

Chemist discovers promising compound for a future drug against Alzheimer's disease

by RUDN UniversityCredit: RUDN UniversityBiochemists from RUDN University (Russia) and the University of Bari (Italy) report a group of compounds that can become a molecular scaffold for new drug

Updated on:June 07,2024

Study finds increased risk of Guillain-Barré after COVID-19 infection

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainHaving a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome w

Updated on: January 11,2024

Study finds increased risk of Guillain-Barré after COVID-19 infection

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainHaving a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome w

Updated on:January 11,2024

Impact of key Alzheimer's protein depends on type of brain cell in which it is produced

Of all the known genetic risk factors for late-onset Alzheimer's disease, the strongest is a gene for the protein called ApoE4. People with one copy of this gene are 3.5 times more likely, on average, to develop Alzheimer's than others, and those with two

Updated on: June 05,2024

Impact of key Alzheimer's protein depends on type of brain cell in which it is produced

Of all the known genetic risk factors for late-onset Alzheimer's disease, the strongest is a gene for the protein called ApoE4. People with one copy of this gene are 3.5 times more likely, on average, to develop Alzheimer's than others, and those with two

Updated on:June 05,2024

Hypertension drug may hold promise for Alzheimer's disease

by American Heart AssociationPET scan of a human brain with Alzheimer's disease. Credit: public domainSeeking new treatments to slow the progression of Alzheimer's disease, researchers fo

Updated on: June 04,2024

Hypertension drug may hold promise for Alzheimer's disease

by American Heart AssociationPET scan of a human brain with Alzheimer's disease. Credit: public domainSeeking new treatments to slow the progression of Alzheimer's disease, researchers fo

Updated on:June 04,2024

Discovery of a disease-specific biomarker for amyotrophic lateral sclerosis

byUniversity of TsukubaCredit: AI-generated imageSporadic amyotrophic lateral sclerosis (ALS) accounts for 90% of all ALS cases. Researchers from the University of Tsukuba discovered that the ed

Updated on: April 09,2024

Discovery of a disease-specific biomarker for amyotrophic lateral sclerosis

byUniversity of TsukubaCredit: AI-generated imageSporadic amyotrophic lateral sclerosis (ALS) accounts for 90% of all ALS cases. Researchers from the University of Tsukuba discovered that the ed

Updated on:April 09,2024

Dial for tuning dopamine, environmental signals found in Parkinson's

by University of Alabama in TuscaloosaC. elegans, seen here as hundreds living on a plate viewed through the lens of a microscope, share roughly half their genes with humans. Credit: The Universi

Updated on: February 05,2024

Dial for tuning dopamine, environmental signals found in Parkinson's

by University of Alabama in TuscaloosaC. elegans, seen here as hundreds living on a plate viewed through the lens of a microscope, share roughly half their genes with humans. Credit: The Universi

Updated on:February 05,2024

Testing effectiveness of a mobile app for assessment of dementia symptoms

by Regenstrief InstituteRegenstrief Institute research scientist Daniel Bateman, M.D. is testing the effectiveness of Brain CareNotes , a novel mobile app for assessment of dementia symptoms. Cre

Updated on: May 05,2024

Testing effectiveness of a mobile app for assessment of dementia symptoms

by Regenstrief InstituteRegenstrief Institute research scientist Daniel Bateman, M.D. is testing the effectiveness of Brain CareNotes , a novel mobile app for assessment of dementia symptoms. Cre

Updated on:May 05,2024

Surgery-free brain stimulation could provide new treatment for dementia

by Ryan O'Hare,Imperial College LondonTemporal interference (TI) is non-invasive and delivers electrical stimulation through electrodes placed on the participant's head. Credit: Imperial

Updated on: January 12,2024

Surgery-free brain stimulation could provide new treatment for dementia

by Ryan O'Hare,Imperial College LondonTemporal interference (TI) is non-invasive and delivers electrical stimulation through electrodes placed on the participant's head. Credit: Imperial

Updated on:January 12,2024

Number of Americans with dementia will double by 2040: Report

(HealthDay)—Nearly 13 million Americans will have dementia by 2040—nearly twice as many as today, a new report says.The number of women with dementia is expected to rise from 4.7 million next year to

Updated on: April 29,2024

Number of Americans with dementia will double by 2040: Report

(HealthDay)—Nearly 13 million Americans will have dementia by 2040—nearly twice as many as today, a new report says.The number of women with dementia is expected to rise from 4.7 million next year to

Updated on:April 29,2024

Group calls on international community to prevent dementia by preventing stroke

by University of Western OntarioDr. Vladimir Hachinski. Credit: Western UniversityThe risk factors for stroke and dementia are the same, and a growing body of evidence demonstrates that preventin

Updated on: June 04,2024

Group calls on international community to prevent dementia by preventing stroke

by University of Western OntarioDr. Vladimir Hachinski. Credit: Western UniversityThe risk factors for stroke and dementia are the same, and a growing body of evidence demonstrates that preventin

Updated on:June 04,2024